{"related:e-JkQ9Ym8PoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Personalized immunomonitoring uncovers molecular networks that stratify lupus patients","url":"https://www.sciencedirect.com/science/article/pii/S0092867416302641","authors":["R Banchereau","R Banchereau S Hong","R Banchereau S Hong B Cantarel","R Banchereau S Hong B Cantarel N Baldwin…"],"year":2016,"numCitations":305,"pdf":"https://www.sciencedirect.com/science/article/pii/S0092867416302641","citationUrl":"http://scholar.google.com/scholar?cites=18081995205588083323&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:e-JkQ9Ym8PoJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18081995205588083323&hl=en&as_sdt=0,5","publication":"Elsevier","p":1,"exp":1596876833762},{"title":"Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.38628","authors":["L Chiche","L Chiche N Jourde‐Chiche","L Chiche N Jourde‐Chiche E Whalen…"],"year":2014,"numCitations":197,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38628","citationUrl":"http://scholar.google.com/scholar?cites=6543850120606524710&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:JiUmjgNt0FoJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6543850120606524710&hl=en&as_sdt=0,5","publication":"Wiley Online Library"},{"title":"Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis","url":"https://academic.oup.com/rheumatology/article-abstract/56/3/477/2731753","authors":["N Jourde"],"year":2017,"numCitations":28,"pdf":"https://academic.oup.com/rheumatology/article/56/3/477/2731753","citationUrl":"http://scholar.google.com/scholar?cites=4971241008336597111&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:d_DBultl_UQJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4971241008336597111&hl=en&as_sdt=0,5","publication":"academic.oup.com"},{"title":"A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus","url":"https://www.sciencedirect.com/science/article/pii/S1074761308002835","authors":["D Chaussabel","D Chaussabel C Quinn","D Chaussabel C Quinn J Shen","D Chaussabel C Quinn J Shen P Patel","D Chaussabel C Quinn J Shen P Patel C Glaser…"],"year":2008,"numCitations":527,"pdf":"https://www.sciencedirect.com/science/article/pii/S1074761308002835","citationUrl":"http://scholar.google.com/scholar?cites=9698513387452990469&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BYSBfIoKmIYJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9698513387452990469&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)","url":"https://ard.bmj.com/content/75/1/196?intcmp=ard&type=0-A&int_source=trendmd&int_medium=cpc&int_campaign=usage-042019","authors":["KC Kalunian","KC Kalunian JT Merrill","KC Kalunian JT Merrill R Maciuca…"],"year":2016,"numCitations":226,"pdf":"https://www.researchgate.net/profile/William_Kennedy8/publication/277782737_A_Phase_II_study_of_the_efficacy_and_safety_of_rontalizumab_rhuMAb_interferon-_in_patients_with_systemic_lupus_erythematosus_ROSE/links/559c0db108ae898ed650bae1/A-Phase-II-study-of-the-efficacy-and-safety-of-rontalizumab-rhuMAb-interferon-in-patients-with-systemic-lupus-erythematosus-ROSE.pdf","citationUrl":"http://scholar.google.com/scholar?cites=9676016627420270240&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:oI4oXtsdSIYJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9676016627420270240&hl=en&as_sdt=0,5","publication":"ard.bmj.com"},{"title":"Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40653","authors":["D Toro‐Domínguez","D Toro‐Domínguez J Martorell‐Marugán…"],"year":2018,"numCitations":23,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40653","citationUrl":"http://scholar.google.com/scholar?cites=2222141411837877261&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:DRxINdeh1h4J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2222141411837877261&hl=en&as_sdt=0,5","publication":"Wiley Online Library"},{"title":"Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled …","url":"https://ard.bmj.com/content/75/11/1909.short","authors":["M Khamashta","M Khamashta JT Merrill","M Khamashta JT Merrill VP Werth","M Khamashta JT Merrill VP Werth R Furie…"],"year":2016,"numCitations":268,"pdf":"https://ard.bmj.com/content/75/11/1909.short","citationUrl":"http://scholar.google.com/scholar?cites=2082742030020632521&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yd8natdi5xwJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2082742030020632521&hl=en&as_sdt=0,5","publication":"ard.bmj.com"},{"title":"Anifrolumab, an anti–interferon‐α receptor monoclonal antibody, in moderate‐to‐severe systemic lupus erythematosus","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.39962","authors":["R Furie","R Furie M Khamashta","R Furie M Khamashta JT Merrill…"],"year":2017,"numCitations":428,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39962","citationUrl":"http://scholar.google.com/scholar?cites=9784314977540500199&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:5-rV7qHeyIcJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9784314977540500199&hl=en&as_sdt=0,5","publication":"Wiley Online Library"},{"title":"Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus","url":"https://journals.sagepub.com/doi/abs/10.1177/0961203309105529","authors":["M Petri","M Petri S Singh","M Petri S Singh H Tesfasyone","M Petri S Singh H Tesfasyone R Dedrick","M Petri S Singh H Tesfasyone R Dedrick K Fry…"],"year":2009,"numCitations":144,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752166/","citationUrl":"http://scholar.google.com/scholar?cites=10294997749903068581&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:pQ1rhugt344J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10294997749903068581&hl=en&as_sdt=0,5","publication":"journals.sagepub.com"},{"title":"Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus","url":"https://ard.bmj.com/content/68/9/1440.short","authors":["C Landolt"],"year":2009,"numCitations":137,"citationUrl":"http://scholar.google.com/scholar?cites=14753855309659503553&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:wfvDHzw5wMwJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14753855309659503553&hl=en&as_sdt=0,5","publication":"ard.bmj.com"}]}